Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Glecaprevir-Pibrentasvir Effective in Patients With HCV, CKDGlecaprevir-pibrentasvir produced high sustained virologic response rates regardless of the underlying HCV genotype in patients with severe chronic kidney disease and HCV infection, a study found.
Hepatitis C Virus: The New RegimensLiver specialists find that HCV patients who have comorbid conditions and treatment-resistant disease may still be candidates for combination therapies.
